Cellulitis caused by Rhizomucor pusillus in a diabetic patient receiving continuous insulin infusion pump therapy.
We have reported a case of primary cutaneous zygomycosis in a diabetic patient receiving continuous insulin infusion pump therapy. We believe this to be the first reported case of a fungal infection associated with the use of an insulin pump. The infection itself was an unusually mild and chronic zygomycosis, possibly due to a low production rate of proteolytic enzymes by a rare opportunistic human pathogen, Rhizomucor pusillus.
Wickline
C L
CL
Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock 79430.
Cornitius
T G
TG
Butler
T
T
D000328:Adult; D002481:Cellulitis / Q000209:etiology*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable / Q000009:adverse effects; D007332:Insulin Infusion Systems / Q000009:adverse effects*; D009091:Mucormycosis / Q000209:etiology*